Wells Fargo & Company Has Lowered Expectations for National Health Investors (NYSE:NHI) Stock Price

National Health Investors (NYSE:NHIGet Free Report) had its price target reduced by equities research analysts at Wells Fargo & Company from $84.00 to $79.00 in a research report issued on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price indicates a potential upside of 9.18% from the stock’s current price.

Other analysts also recently issued reports about the company. Weiss Ratings restated a “buy (b)” rating on shares of National Health Investors in a research note on Friday, March 27th. Truist Financial reduced their price target on National Health Investors from $92.00 to $89.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $86.67.

Read Our Latest Report on NHI

National Health Investors Stock Performance

Shares of NYSE NHI traded down $0.94 during midday trading on Monday, hitting $72.36. 57,828 shares of the company’s stock were exchanged, compared to its average volume of 335,104. The company’s 50 day moving average price is $79.59 and its 200 day moving average price is $80.57. The firm has a market capitalization of $3.51 billion, a PE ratio of 23.34, a price-to-earnings-growth ratio of 3.82 and a beta of 0.52. National Health Investors has a 12 month low of $68.80 and a 12 month high of $91.38. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83.

National Health Investors (NYSE:NHIGet Free Report) last released its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.39). The firm had revenue of $115.13 million during the quarter, compared to the consensus estimate of $70.22 million. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The business’s revenue for the quarter was up 28.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.15 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, analysts predict that National Health Investors will post 5.07 earnings per share for the current fiscal year.

Institutional Trading of National Health Investors

Institutional investors and hedge funds have recently modified their holdings of the business. International Assets Investment Management LLC acquired a new position in National Health Investors in the 4th quarter worth about $27,000. EverSource Wealth Advisors LLC increased its holdings in National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $33,000. GAMMA Investing LLC increased its stake in shares of National Health Investors by 41.8% in the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 136 shares during the period. Finally, Key Capital Management INC acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $47,000. 62.51% of the stock is currently owned by institutional investors.

About National Health Investors

(Get Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Further Reading

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.